|
|
| Derisking Biomanufacturing: Why A CDMO In Poland Might Be Your Secret Weapon | As the U.S. government works to pass the BIOSECURE Act, which aims to the protect the IP of U.S. pharma companies, the EU is simultaneously seeking to increase innovation across the European biomanufacturing industry. Amid these cultural shifts, sponsors are considering the best global partnerships for their goals. |
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Twenty-eight years at Gilead, but Reza Oliyai’s new pursuit is no mere second act. He establish Oliyai Consulting Corporation, focused on Chemistry and Manufacturing Controls (CMC), to teach others his series of guiding "triads" to apply to all activities related to drug development and manufacturing outsourcing. |
|
|
More Case Studies: Managing Change In Vaccine Production | By Eric Doerr, Manufacturing Sciences and Analytical Technology, Sanofi, Toronto | Part two of this series digs into real-world examples from Sanofi for getting the right stakeholders on board when altering a process or changing equipment. |
|
|
|
|
In Vitro Assessment Of Fc Functional Activity | Poster | Abzena | By employing a comprehensive panel of assays to characterize the Fc-mediated activity of antibodies, Fc fusion proteins, or ADCs, researchers can streamline development and expedite the path to clinic. |
|
|
|
|
|
Precision Volume Accounting In Fed-Batch Cultures | Application Note | By Sam van Herwaarden, Abhinav Malhotra, et al., Culture Biosciences | Are you searching for a better way to calculate growth rate? Explore a new approach that performs the rate calculations using a simple method to correct for volume changes. |
|
|
|
Laboratory Services | Singota Solutions | Singota Solutions has a variety of equipment and instrumentation available for formulation, product development, microbiology, testing and analytical activities. Select equipment, methods and instrumentation are validated and/or GMP compliant. |
|
|
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
